
Thursday, May 15, 2025 10:54:14 PM
I have also read some of the highly liked posts from today.
I need help understanding a few things.
1. What was Lebby’s mistake ? Please be specific, don’t tell me he “lied” to us, tell me what the exact lie or misleading information was I want to know what I missed.
2. Why do we feel that this time around things are different ? I felt like I’m hearing the same stuff again that we have a great product and we are working with customers, only thing different is that ramp up was pushed from 2025 to 2028. What else is making people feel different this time around?
3. If ramp up is not till 2028 how are we financing the next 2-3 years ? What’s is our burn rate and at this low share price how much dilution do we expect ?
For full disclosures I have been here more than 15 years, at one point I held 110,000 shares, I currently hold 40,000 (20,000 I bought a week ago)
And I have lost a lot of money here.
Please help me understand what is going on here to the best of your ability. Bullish and bearish posts appreciated as long as they are useful and respectful.
Thank you in advance
Best
Recent LWLG News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/02/2025 08:41:12 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/02/2025 08:39:11 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/02/2025 08:32:46 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 06/20/2025 08:54:42 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/20/2025 08:17:15 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/16/2025 08:11:08 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/13/2025 09:02:04 PM
- Form DEFR14A - Revised definitive proxy soliciting materials • Edgar (US Regulatory) • 04/30/2025 08:05:23 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/28/2025 09:10:02 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 03/28/2025 09:19:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/21/2025 09:11:35 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 03/21/2025 09:08:27 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/18/2025 09:03:04 PM
- Lightwave Logic to Host Annual Meeting of Shareholders on May 15, 2025 • PR Newswire (US) • 03/17/2025 12:30:00 PM
- Lightwave Logic to Attend the 37th Annual ROTH Conference • PR Newswire (US) • 03/11/2025 12:30:00 PM
- Lightwave Logic and Polariton Technologies Expand Technical Partnership to Accelerate Introduction of 400Gb/s per lane and beyond for AI and Datacenter Optical Links • PR Newswire (US) • 03/10/2025 08:01:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/03/2025 10:41:24 PM
- Lightwave Logic to Host Special Call on March 13, 2025 • PR Newswire (US) • 03/03/2025 09:01:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/26/2025 07:47:24 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/20/2025 09:06:54 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/19/2025 09:37:05 PM
- Lightwave Logic to Attend the 2025 SPIE Photonics West Conference • PR Newswire (US) • 01/27/2025 09:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/17/2025 09:04:19 PM
- Lightwave Logic Director Frederick Leonberger to Retire from Board of Directors and Transition to Company's Advisory Board • PR Newswire (US) • 01/03/2025 01:30:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2025 10:02:39 PM
Glidelogic Corp. Announces Release of First AI-Generated Novel "The Thirteenth Proposal" • GDLG • Jul 11, 2025 12:20 PM
Fifty1 AI Labs' REVIVE Clinical Trial Redefines Long COVID Treatment, Pioneering AI-Driven Therapies and Propelling Fifty 1 Labs, Inc. Toward $50M Valuation and Global Biotech Leadership • FITY • Jul 10, 2025 8:30 AM
Aspire Biopharma Holdings, Inc., Announces Positive Consumer Feedback from Company Sampling of BUZZ BOMB™, its New Sublingual Pre-Workout Supplement • ASBP • Jul 9, 2025 9:15 AM
Breaking Through: Systemic Genetic Medicines for Hard-to-Treat Cancers • IBRX • Jul 9, 2025 9:00 AM
Fifty 1 Labs, Inc. Announces Bold Expansion Plan Powered by Nobel Prize Laureate Management Team, Cutting-Edge AI Healthcare Innovation and $350K Leadership Investment • FITY • Jul 8, 2025 8:30 AM
Avant Technologies and Partner, Ainnova, Launch Transformative Preventative Care Model for Chronic Patients Across Latin America • AVAI • Jul 8, 2025 8:00 AM